R&D Paving the road to functionally active antibody drugs Antibody drugs have reshaped how we treat diseases.
R&D Prediction is very difficult, especially if it’s about the f... In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acceleration of antibody therapeutics.
News Regeneron's Inmazeb named Galien's Best Biotech Product The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded its
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
